Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam dose and preoperative anxiety effects on perioperative amnesia
IRCT20200213046484N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of midazolam in anxiety disorder (6 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Amnesia, Retrograde amnesia and 1 more. Started May 2020; status: completed.
02
Drugs
midazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20200213046484N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200213046484N1.